LFCR
Lifecore Biomedical
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: LFCR
- PE Ratio
The current PE ratio of LFCR cannot be calculated, as the latest EPS is not present. Lifecore Biomedical's last PE ratio on record was 28.57 in August 2024.
LFCR PE ratio history
The mean historical PE ratio of Lifecore Biomedical over the last ten years is 103.86. Looking back at the last ten years, LFCR's PE ratio peaked in the May 2019 quarter at 942, with a price of $9.42 and an EPS of $0.01. The May 2024 quarter marked the lowest point at 14.41, with a price of $5.62 and an EPS of $0.39.
Lifecore Biomedical PE ratio by year
Maximum annual increase: 5,934.59% in 2019
Maximum annual decrease: -62.88% in 2012
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $6.72 | -$1.27 |
| 2024 | 14.41 | N/A | $5.62 | $0.39 |
| 2023 | N/A | N/A | $7.94 | -$3.32 |
| 2022 | N/A | N/A | $9.87 | -$3.97 |
| 2021 | N/A | N/A | $11.97 | -$1.1 |
| 2020 | N/A | N/A | $10.67 | -$1.31 |
| 2019 | 942 | 5,934.59% | $9.42 | $0.01 |
| 2018 | 15.61 | -55.4% | $14.05 | $0.9 |
| 2017 | 35 | N/A | $13.65 | $0.39 |
| 2016 | N/A | N/A | $11.46 | -$0.43 |
| 2015 | 28.58 | 71.34% | $14.29 | $0.5 |
| 2014 | 16.68 | 4.58% | $12.01 | $0.72 |
| 2013 | 15.95 | 10.53% | $13.88 | $0.87 |
| 2012 | 14.43 | -62.88% | $7.07 | $0.49 |
| 2011 | 38.87 | -5.82% | $5.83 | $0.15 |
Lifecore Biomedical PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | N/A | N/A | $3.72 | N/A |
| Dec 2025 | N/A | N/A | $8.18 | N/A |
| Sep 2025 | N/A | N/A | $7.36 | N/A |
| May 2025 | N/A | N/A | $6.72 | -$1.27 |
| Feb 2025 | N/A | N/A | $5.61 | -$1.44 |
| Nov 2024 | N/A | N/A | $7.31 | -$0.51 |
| Aug 2024 | 28.57 | 98.27% | $6 | $0.21 |
| May 2024 | 14.41 | N/A | $5.62 | $0.39 |
| Feb 2024 | N/A | N/A | $8.07 | -$0.67 |
| Nov 2023 | N/A | N/A | $7.51 | -$2.38 |
| Aug 2023 | N/A | N/A | $8.39 | -$3.28 |
| May 2023 | N/A | N/A | $7.94 | -$3.32 |
| Feb 2023 | N/A | N/A | $5.85 | -$3.9 |
| Nov 2022 | N/A | N/A | $8.37 | -$3.15 |
| Aug 2022 | N/A | N/A | $10.19 | -$4.02 |
LFCR Price vs fair value
LFCR average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
PE comparison
LFCR PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OPK Opko Health Inc | N/A | $1.1B |
| ORGO Organogenesis Holdings Inc | N/A | $319.11M |
| LFCR Lifecore Biomedical Inc | N/A | $217.18M |
Frequently asked questions
What is Lifecore Biomedical's PE ratio?
The current price to earnings ratio of LFCR cannot be determined, as its EPS is not present.
What is the highest PE ratio for LFCR?
The highest quarterly PE ratio in the last ten years has been 942 and it was in the May 2019 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.